Skip to main content

Training health care providers to administer VIA as a screening test for cervical cancer: a systematic review of essential training components

This article has been updated

Abstract

Background

Training health care providers to administer visual inspection after application of acetic acid (VIA) is paramount in improving cervical cancer screening services for women in low- and middle-income countries. The objective of this systematic review was to create a framework of essential VIA training components and provide illustrating examples of how VIA training programs can be carried out in different clinical settings.

Methods

A systematic review of PubMed, Embase, and Web of Science (from 2006 to 2021) was undertaken. Our inclusion criteria comprised articles reporting on implemented cervical cancer screening programs using VIA in a screen-and-treat approach. Trained health care providers with any level of health education were included, and the outcome of interest was the reporting of training components. Data were extracted by two reviewers, and a narrative synthesis of the training programs was performed. We developed a framework of seven essential training components and applied it to assess how training courses were conducted in different settings.

Results

13 primary studies were eligible for inclusion, including 2,722 trained health care providers and 342,889 screened women. Most training courses lasted 5–7 days and included theoretical education, practical skill development, and competence assessment. It was unclear how visual aids and training in client counselling and quality assessment were integrated in the training courses. After the training course, nearly all the VIA training programs made provisions for on-job training at the providers’ own clinical settings through supervision, feedback, and refresher training.

Conclusions

This study demonstrates the feasibility of implementing international training recommendations for cervical cancer screening in real-world settings and provides valuable examples of training program implementation across various clinical settings. The diverse reporting practices of quality indicators in different studies hinder the establishment of direct links between these data and training program effectiveness. To enhance future reporting, authors should emphasize specific training components, delivery methods, and contextual factors. Standardized reporting of quality indicators for effective evaluation of VIA training programs is recommended, fostering comparability, facilitating research, and enhancing reporting quality in this field.

Peer Review reports

Introduction

Cervical cancer ranks as the fourth most frequently diagnosed cancer and the fourth leading cause of cancer death in women, with an annual estimated 604,127 cases and 341,831 deaths worldwide [1]. A disproportionate number occur among women living in low-and-middle-income countries (LMICs) [2]. The World Health Organization (WHO) recommended in their guidelines published in 2013 visual inspection after application of acetic acid (VIA) as the most feasible and affordable alternative to cytology screening for the LMICs [3]. VIA involves naked-eye examination of the uterine cervix with appropriate illumination after application of 3–5% acetic acid solution [3]. The test aims to detect precursor lesions as well as early cervical cancers in asymptomatic women [3]. VIA is widely used as a screening test in LMICs, often in a ‘screen and treat’ approach where screen-positive women are offered immediate treatment [4]. Such an approach has been demonstrated to reduce the number of clinic visits by women, improve compliance with treatment, and make the program efficient [4].

The paradigm of cervical cancer screening is evolving rapidly [4]. WHO updated their guideline on cervical cancer screening in July 2021 [5], which recommends Human Papillomavirus (HPV) DNA detection as the gold standard for primary testing for cervical cancer screening, rather than VIA or cytology in a ‘screen and treat’ approach for women in the general population. For women living with Human Immunodeficiency Virus (HIV), a ‘screen, triage and treat’ approach is recommended when using HPV detection [5]. Despite these recommendations, many countries with limited resources will have to continue with VIA as the primary screening test till they have enough resources to introduce HPV detection tests [4]. In the HPV screen and treat algorithm, health care providers will still need similar clinical training to visually triage women eligible for treatment. In some countries, VIA will have a key role as a triage test even after introduction of HPV test, especially in countries with high HIV prevalence [4].

VIA can generally be performed by health care providers after a short period of training [3]. The interpretation of the test is based on the detection of a well-defined opaque acetowhite area on the transformation zone of the cervix appearing one minute after the application of acetic acid solution [3]. Studies have found that the provider’s professional background (e.g., physicians, nurses, health workers) does not influence the test accuracy of VIA [6], and that trained non-physicians can perform VIA screening while maintaining high-quality services [3, 7]. However, due to the subjective nature of the test, success of the screening program depends on the high-quality training of providers [4]. Worldwide, there are many training manuals providing guidelines on VIA training [7,8,9,10,11,12,13,14]. However, at present, it is unknown to what extent the providers of VIA are trained or how far the guidelines on training are adhered to. Designing an effective training program can be a complex process, and although most of the principles, steps, and interpretations remain similar, the contexts and settings may differ. The objective of this systematic review was to create a framework of essential VIA training components and provide illustrating examples of how VIA training programs can be carried out in different clinical settings.

Methods

The review protocol is registered with Prospero (CRD42021220497). The review process and reporting were guided by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines [15] (Table S1).

Eligibility criteria

We included studies reporting on implemented cervical cancer screening programs using VIA in a screen-and-treat approach. Our inclusion criteria comprised articles reporting on programs implemented after the year 2005. This specific timeframe was chosen because it aligns with a landmark publication in 2005, which presented essential training components in VIA screening, representing an international consensus among members of the Alliance for Cervical Cancer Prevention (ACCP) [8]. The participants (trainees) could have any level of health education, and the outcome of interest was the reporting of the VIA training components. We included studies published in English in peer-reviewed journals, and excluded studies only available as abstracts.

Literature search

Searches were conducted in PubMed, Embase, and Web of Science; the initial search was undertaken in December 2020 and updated in October 2021 (Table S2). We searched for papers published after 2005. PICO forms (Population, Intervention, Control, and Outcome) were used to create a structured and precise search strategy (Table S3). The search strategy and history were critically assessed using the evidence-based checklist of peer review of electronic search strategies [16]. The reference lists of included articles were also hand searched for further relevant articles.

Study selection

The study assessment was conducted in Covidence by two reviewers (TB and LC). First, TB and LC independently reviewed a randomly selected 10% of the titles and abstracts. The interrater reliability (IRR) was measured using Cohen’s Kappa coefficient (κ). It was predetermined that the two reviewers would individually screen abstracts until they reached a κ > 0.7. After reaching this agreement, TB continued with the title and abstract assessment. The full text assessment was conducted independently by both TB and LC. Any discrepancies between the two reviewers were resolved through discussion. If agreement could not be reached, the project leader (AC) was consulted who had the final say in the decision. Excluded abstracts and articles were categorized in Covidence and made available to the review team to ensure transparency throughout the process.

Data extraction

Information was extracted for each study using a standardized form, which included the following variables: the contextual settings (country, healthcare setting, and year of VIA implementation), target population eligible for screening, trainees (number and professions), information relating to the training program, and results (timeframe of follow-up, screening participation rates, and VIA positivity (+) rates). Data extraction was carried out by TB and LC. Disagreements were resolved by discussion, and if agreement could not be reached, the project leader (AC) had the final say.

Framework to conceptualize VIA training

Informed by the Alliance for Cervical Cancer Prevention (ACCP) [8], and after discussion with screening experts at the International Agency for Research on Cancer (IARC), a framework to conceptualize essential VIA training components was developed (Table 1).

Table 1 Description of essential training components

Data synthesis

When synthesizing the reported information on the VIA training, one reviewer (TB) carried out a dichotomy coding (Yes/No) for the presence of the seven components in each of the included studies. LC checked the coding, while AC was consulted for consensus on disagreements. Since many authors did not describe their interventions in detail probably due to word limitations of publications, we contacted all the corresponding authors to obtain more information about their training intervention. Out of 13 corresponding authors contacted, nine responded and provided additional information about the VIA training.

Results

Search results

The database searches identified 4867 records: after title and abstract screening, 35 full papers were assessed for eligibility (Fig. 1). In total, 13 primary studies were included in this systematic review [16,17,18,19,20,21,22,23,24,25,26,27,28,29].

Fig. 1
figure 1

Flow diagram. Prisma flow chart of search results and study selection

Characteristics of included studies

The included studies reported on implemented screen-and-treat programs in Botswana [27], Burkina Faso [19], Cameroon [26], Eswatini [28], Ethiopia [20], Guyana [18], India [21], Indonesia [17], Malawi [22], Nigeria [23], Tanzania [24, 29], and Zambia [25]. The programs were delivered in community- or hospital-based clinics, with many using existing health facilities, such as HIV clinics. The years the training programs were conducted were between 2006 [25] and 2017 [22]. Four studies [18, 20, 22, 27] specifically targeted HIV positive women in their screening approach. In total, the studies included in the final analysis reported to have screened 342,889 women, ranging from 556 women screened in 5 days [24] to 102,942 women screened in 7 years [25]. The total number of VIA trainees was 2,722 providers, ranging from 3 [28] to 2216 [17], although we note two studies [25, 27] did not report the number of trainees. The trainees included nurses [17,18,19,20, 22,23,24,25,26,27,28,29], midwives [16,17,18,19,20, 23, 27, 28], physicians [16,17,18,19,20,21, 23, 29], and other health care workers with less formal health education [18, 19, 24, 25, 30]. More information about the included studies is available in Table 2.

Table 2 Characteristics of included studies

VIA training courses

The VIA training courses were heterogeneous with substantial variability in their objectives, structure, content, duration, and reporting. In all studies, VIA was implemented in a screen-and-treat approach, where 5 studies [24,25,26,27,28,29] integrated digital technologies to enhance performance of VIA, such as using digital imaging [27] or smartphones [29]. Table 3 outlines the reported training components in each of the included studies.

Table 3 The reporting of essential components for VIA training courses

Most training programs were based on international training guidelines, such as the WHO’s guide to essential practice in comprehensive cervical cancer control [12, 13] and adapted to the specific setting. One study [27], undertaken in Botswana, trained nurses because they were more available than physicians and familiar with performing pelvic exams. Another study [21] trained private practitioners in India, based on the long-standing association of working with doctors in public health programs. A third study [23] trained community health workers in Nigeria because nurses and doctors were largely absent in rural communities.

Training duration

Most of the VIA training courses lasted between 5 and 7 days. In one study [20], for Ethiopian nurses and midwives, the training course lasted for 10 days, while for obstetricians and gynecologists, it was 5 days. In contrast, one study [17] implemented a standardized 5-day training course for over 2000 trainees in Indonesia: the same training course was provided to doctors as well as community health workers. Three studies [24,25,26,27] organized training courses that lasted between 2 and 8 weeks to train the trainees in both VIA screening and new digital technology. Another study [29] included providers who had previously completed a 6-days training course and screened more than 50 women, before organizing a new training program focusing on technical training on smartphone-enhanced VIA.

Theoretical training

All studies reported a theoretical educational component in the training program. In general, however, the included studies reported limited information about the content of the theoretical sessions. The main areas covered were education on: female genital anatomy and cervical cancer pathophysiology; the VIA screening procedure; recognition and interpretation of features on VIA; appropriate treatment and referral of VIA positive women; and, infection prevention. Some of the training courses also included information about specific considerations, such as characteristics of cervical cancer in HIV positive women. One study [18] chose to arrange adaptive educational sessions that focused on the trainees’ weaknesses identified through an initial assessment of baseline knowledge and skills.

Practical hands-on

All the reported training courses included practical hands-on sessions, either classroom-based or clinic-based, although the sessions were conducted in different ways. In one study [17], the trainees went through a one-day live demonstration of VIA, after which they were able to practice on women in a clinic under supervision of appropriately trained professionals. Another study [24] reported that trainees had four days of hands-on training with women called from the community to undergo VIA. A third study [23] reported that trainees were trained in the classroom on techniques related to insertion of a vaginal speculum (with identification of cervix using a pelvic model), visual inspection of the cervix, test sampling, and application of acetic acid (simulated learning).

Client counselling

Overall, the included studies contained limited information regarding how trainees were trained in client counselling. One study [22] reported that the lecture topics included counselling and informed choice, while the classroom-based practical sessions covered post-test counselling of patients. Another study [19] used checklists to validate the trainees’ skills in interpersonal communication and counselling. Although the studies reported limited information on the training of client counselling, many of the included studies emphasized that participating women were counselled in the clinical setting about the screening techniques and any side effects that may arise. One study [24] described that healthcare staff explained to the women in Swahili the risks and benefits of the VIA screening procedure, including the meaning and consequences of a positive test and the availability of treatment. One study [27] highlighted that the technology produced high resolution images that could be used to educate and counsel the women, and this was included as a component of the training program.

Visual aids

Some of the studies reported the use of visual aids to support training, such as photographic images [19, 23, 24], flash cards [20, 28], educational videos [20], and PowerPoint presentations [28]. One study [24] reported that several de-identified patient cervical images of VIA-positive and -negative examples were shown to ensure that the trainees could practice categorizing clinical impression. Two studies [19, 23] reported using anatomic models for identification of the cervix.

Competency assessment

Several studies reported that the trainees’ competence was assessed at the end of the training course. In one study [17], each trainee had to perform VIA on 100 women, out of which the 2–3 VIA positive cases were confirmed by the supervisor. Another study [29] considered the trainees as graduated from the training program based on three key factors: the number of women screened, the level of agreement with reviewers, and meeting a specific threshold for the number of VIA positive women. In one study [27], each trainee had to successfully perform 100 VIA examinations, 100 digital photographs, and 35 cryotherapies.

Quality assurance

Few studies reported on including a quality-assurance module into the general training. One study [23] reported that the educational lectures covered topics on recording, appropriate documentation, and referral systems. Another study [19] let the trained providers collect and monitor the data together with the researchers, which allowed the providers to visualize progress, analyze trends, evaluate themselves, and identify potential bottlenecks in service provision. Furthermore, this approach empowered the trained providers to track progress, identify gaps, and take corrective actions to remedy any shortcomings, thereby reaching more successful outcomes [19].

Continued training in VIA

After the training course, nearly all the VIA training programs made provisions for on-job training at the providers’ own clinical settings through supervision, feedback, and refresher training. On-job supervision was provided by allowing the trained providers to work in pairs with experienced gynecologists or nurses who supervised their practice. Regular supportive supervision visits from experts were provided to offer transfer of learning. In one study [25], nurses visited rural facilities every three months for purposes of quality assurance and continued medical education. On-job feedback and mentoring were provided by experts reviewing the cervical images, captured during VIA by the providers, on a regular basis. Such regular meeting with experts offered feedback and education [28], increased understanding [27], and arrival at consensus opinions for treatment options [26]. Regularly organized refresher training and workshops were also used to retain or enhance VIA competency.

Needs for additional training or mentorship of the providers were identified through measuring the VIA + rates as a performance quality indicator for monitoring and evaluation purposes. Studies have shown that the VIA + rate in general population of women aged 30–60 years ranges between 5 and 10% [31]. The positivity rates tend to be higher in settings with a higher HIV prevalence. If the test positivity is too low, there is a possibility of missing the disease, while if it is too high, there is a higher possibility of false positives [31]. However, it is more important to measure VIA + serially over time to check if the rate is stable. In one study [28], the VIA + rate was at 16% after the initial training but increased to 40% after nine months. After refresher training and continued mentoring were implemented, the positivity rate decreased to an average of 6.3%, which was maintained all along the program [28]. In another study, the proportion of women considered to have inadequate VIA test reduced following additional training of nurses to better expose the endocervical canal [26]. Although all the included studies reported the average VIA + rate over the length of their screening program, only four studies [19, 25, 26, 28] reported serial point estimates of the VIA + rate over time (Fig. 2). These four studies all provided prolonged training after the initial training course and showed that the VIA + rates reached the expected level over time.

Fig. 2
figure 2

VIA positivity rates over time. Four studies reported serial point estimates of the VIA + rate in percentage over years. The four studies all provided prolonged training after the initial training course and showed that the VIA + rates reached the expected level over time. The VIA + in general population of women aged 30–60 years normally ranges between 5 and 10%

Discussion

In this systematic review, we developed a framework to conceptualize essential VIA training components and have applied that framework to the literature to determine how extensive VIA training has been carried out in different settings. Our findings indicate that implemented VIA training programs have been carried out in line with international recommendations [7,8,9,10,11], but more importantly, that the training recommendations are feasible to implement in real settings. This observation holds paramount importance as previous studies have shown that with good training and sustained quality assurance and monitoring, screening of women with VIA followed by appropriate management of screen-positive women can reduce cervical cancer incidence and mortality [4, 32]. However, VIA performance varies widely, and the VIA + rates have shown high variability between countries [33] and within the same program or setting [34]. The sensitivity reported from some real programmatic settings ranged from 25 to 82% [33, 35]. Inconsistency across studies reflects the substantial subjectivity in interpreting visual tests by different providers, due to different levels of competencies, training methods, monitoring and quality assurance, and the low reproducibility of visual inspection methods [33]. Notably, the accuracy of VIA has been found to increase significantly by study phase [33], emphasizing the importance of experience, continuous training, and supervision.

A major pitfall in training is the lack of specific recommendation from international organizations. One size may not fit all, but some training guidance on the minimum requirements (e.g., duration of training, number of cases to be observed, and trainees-to-trainer ratio) will be very helpful. As the new WHO guidelines [5] refer to the screen-and-treat approach based on HPV primary screening followed by visual triage for treatment, it is important to have clear standards on how training should be conducted. Health care providers must be trained to visually triage women eligible for ablative treatment (cryotherapy or thermo-coagulation) based on their HPV status and not on the presence of acetowhite lesions. Still, VIA will have a key role as a triage test after introduction of HPV test in some countries. A high proportion of women with a positive HPV test will not necessarily have cervical precancer or cancer, and to reduce the referral for all HPV-positive women for colposcopy and/or treatment, many countries will use VIA to triage HPV-positive women [4]. In setting with high prevalence of HIV, health care providers will continue to perform VIA to triage women. WHO Academy is collaborating with IARC to develop a comprehensive learning program for providers of cervical cancer screening and treatment.

We found that many of the included studies reported that their training program was adapted to their specific settings, but without explaining which kind of adaptations were done and on what basis. Without a complete published description regarding the details of the training programs, it can be challenging to implement courses that are known to be successful and replicate or build on the research findings [36]. In a systematic review on the context in which cervical cancer screening is delivered in India, the authors mention that many of the included studies did not provide any information on the training [37]. To improve future reporting on training to support cancer screening, we encourage authors to highlight the specific components of the training program, including how the training was delivered, and in what context. There are similar reporting tools in the literature, which could be adapted for this purpose; for example, the TIDieR (Template for Intervention Description and Replication) checklist [36] that is used to report interventions in healthcare.

Initially, our aim was to explore the success of each training program by analyzing quality performance indicators, such as VIA + rates, treatment, and referral rates. However, the quality performance indicators were too diversely collected and reported between studies to link these data to the effectiveness of training programs. We found indications that VIA + rates can reach an acceptable level over time when prolonged training is provided. However, this finding is based on data from only four studies, which emphasizes the need for more data. Monitoring and evaluation of services are required, and we recommend that quality performance indicators are collected and monitored regularly. One proposition on the collection of data is the CanScreen5 – Cervical Cancer Screen-and-treat Quantitative Data Collection Form [38], which focuses on the target population, screening test outcomes, further assessment outcomes, cancer staging, and treatment.

For future reviewers to be able to explore the effectiveness of VIA training programs, we recommend a more homogeneous reporting of the quality indicators. We recommend that, at the very least, studies report VIA + rates measured after training along with corresponding point estimates over time. We propose that articles on VIA training include a table containing monthly or quarterly data (depending on the study duration) on the following quality indicators as a minimum: Number of women screened using VIA, VIA + rate, same-day treatment rates (cryotherapy or thermo-coagulation), and referral rates for excision procedures. This approach will provide a more comprehensive and standardized representation of the study findings, facilitating comparisons, and improving the overall quality of reporting in the research field.

Study limitations

Our search strategy was designed to identify studies on provider-directed interventions on cancer screening participation among disadvantaged populations, which led to some relevant keywords, such as “VIA”, being missing. Nevertheless, the search includes relevant keywords related to cervical cancer screening, provider training, and screening participation. We also conducted manual searches to identify additional papers of interest, ensuring a comprehensive approach. Additionally, we acknowledge that our restriction to studies published in English may have led to the oversight of relevant studies, particularly in regions where English is not the primary language.

Conclusion

This study demonstrates the feasibility of implementing international training recommendations for cervical cancer screening in real-world settings and provides valuable examples of training program implementation across various clinical settings. However, the diverse reporting practices of quality indicators in different studies hinder the establishment of direct links between these data and training program effectiveness. To enhance future reporting on training programs supporting cancer screening, we encourage authors to emphasize specific training components, delivery methods, and contextual factors. For effective evaluation of VIA training programs, we recommend a more standardized reporting of quality indicators. At the very least, studies should report VIA + rates measured after training, along with corresponding point estimates over time. Additionally, we suggest the reporting of monthly or quarterly data for essential quality indicators. Adopting these practices will improve comparability, facilitate research, and enhance the overall quality of reporting in this field.

Data Availability

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Change history

  • 21 October 2023

    The name of author Isabel Mosquera Metcalfe should be: First name: Isabel; Last name: Mosquera Metcalfe

Abbreviations

ACCP:

the Alliance for Cervical Cancer Prevention

HIV:

Human Immunodeficiency Virus

HPV:

Human Papillomavirus

IARC:

the International Agency for Research on Cancer

IRR:

Interrater Reliability

κ:

Cohen’s Kappa coefficient

LMICs:

Low- and Middle- Income Countries

PICO:

Population, Intervention, Control, and Outcome

PRISMA:

Preferred Reporting Items for Systematic Reviews and Meta-Analyses

VIA:

Visual Inspection after application of acetic acid

VIA+:

VIA positivity

WHO:

The World Health Organization

References

  1. International Agency for Research on Cancer. Cancer Today. 2021. Available from: https://gco.iarc.fr/today/online-analysis-pie?v=2020&mode=cancer&mode_population=continents&population=900&populations=900&key=total&sex=2&cancer=39&type=0&statistic=5&prevalence=0&population_group=0&ages_group%5B%5D=0&ages_group%5B%5D=17&nb_items=7&group_cancer=1&include_nmsc=1&include_nmsc_other=1&half_pie=0&donut=0. Accessed 22 November 2021

  2. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. https://doi.org/10.3322/caac.21492.

    Article  Google Scholar 

  3. World Health Organization. WHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention. Geneva: WHO; 2013.

    Google Scholar 

  4. Mittal S, Basu P, Lucas E. Atlas of visual inspection of the cervix with acetic acid for screening, triage, and assessment for treatment. 2020. Available from: https://screening.iarc.fr/atlasvia.php. Accessed 08 November 2021.

  5. World Health Organization. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition. Geneva: WHO; 2021.

  6. Sauvaget C, Fayette J-M, Muwonge R, Wesley R, Sankaranarayanan R. Accuracy of visual inspection with acetic acid for cervical cancer screening. Int J Gynecol Obstet. 2011;113(1):14–24. https://doi.org/10.1016/j.ijgo.2010.10.012.

    Article  Google Scholar 

  7. World Health Organization. WHO guidelines: use of cryotherapy for cervical intraepithelial neoplasia. Geneva: WHO; 2011.

    Google Scholar 

  8. Blumenthal PD, Lauterbach M, Sellors J, Sankaranarayanan R. Training for cervical cancer prevention programs in low-resource settings: focus on visual inspection with acetic acid and cryotherapy. Int J Gynecol Obstet. 2005;89:30–S7.

    Article  Google Scholar 

  9. JHPIEGO. Cervical Cancer Prevention. Guidelines for low-resource settings. Baltimore: Jhpiego; 2007.

    Google Scholar 

  10. Alliance for Cervical Cancer Prevention. Planning and implementing cervical cancer prevention and control programs: a manual for managers. Seattle: ACCP; 2004.

    Google Scholar 

  11. International Agency for Research on Cancer. Tutorial: a training course in visual inspection with 5% acetic acid (VIA). 2015. Available from: https://learning.iarc.fr/edp/courses/tutorial-course-via/ Accessed 10 October 2021.

  12. World Health Organization. Comprehensive cervical cancer control: a guide to essential practice. Geneva: WHO; 2006.

    Google Scholar 

  13. World Health Organization. Comprehensive Cervical Cancer Control: a guide to essential practice. Geneva: WHO; 2014.

    Google Scholar 

  14. Sellors JW, Sankaranarayanan R. Colposcopy and treatment of cervical intraepithelial neoplasia: a beginner’s manual. Lyon: IARC; 2003.

    Google Scholar 

  15. Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.

    Article  Google Scholar 

  16. McGowan J, Sampson M, Salzwedel DM, Cogo E, Foerster V, Lefebvre C. PRESS peer review of electronic search strategies: 2015 guideline statement. J Cancer Epidemiol. 2016;75:40–6.

    Google Scholar 

  17. Nuranna L, Aziz MF, Cornain S, et al. Cervical cancer prevention program in Jakarta, Indonesia: see and treat model in developing country. J Gynecol Oncol. 2012;23(3):147.

    Article  Google Scholar 

  18. Martin CE, Tergas AI, Wysong M, Reinsel M, Estep D, Varallo J. Evaluation of a single-visit approach to cervical cancer screening and treatment in Guyana: feasibility, effectiveness and lessons learned. J Obstet Gynaecol Res. 2014;40(6):1707–16.

    Article  Google Scholar 

  19. Ouedraogo Y, Furlane G, Fruhauf T, et al. Expanding the single-visit approach for cervical cancer prevention: successes and lessons from Burkina Faso. Glob Health Sci Pract. 2018;6(2):288–98.

    Article  Google Scholar 

  20. Shiferaw N, Salvador-Davila G, Kassahun K, et al. The single-visit approach as a cervical cancer prevention strategy among women with HIV in Ethiopia: successes and lessons learned. Glob Health Sci Pract. 2016;4(1):87–98.

    Article  Google Scholar 

  21. Shikha S, Smita J, Nayanjeet C, et al. Experience of a ‘Screen and treat’ program for secondary prevention of cervical cancer in Uttar Pradesh, India. J Obstet Gynaecol Res. 2020;46(2):320–7.

    Article  Google Scholar 

  22. Talama GC, Shaw M, Maloya J, et al. Improving uptake of cervical cancer screening services for women living with HIV and attending chronic care services in rural Malawi. BMJ Open Qual. 2020;9(3):e000892.

    Article  Google Scholar 

  23. Awolude OA, Oyerinde SO, Akinyemi JO. Screen and triage by community extension workers to facilitate screen and treat: task-sharing strategy to achieve universal coverage for cervical cancer screening in Nigeria. J glob Oncol. 2018;4:1–10.

    Google Scholar 

  24. Bernstein M, Hari A, Aggarwal S, et al. Implementation of a human papillomavirus screen-and-treat model in Mwanza, Tanzania: training local healthcare workers for sustainable impact. Int Health. 2018;10(3):197–201.

    Article  Google Scholar 

  25. Parham GP, Mwanahamuntu MH, Kapambwe S, et al. Population-level scale-up of cervical cancer prevention services in a low-resource setting: development, implementation, and evaluation of the cervical cancer prevention program in Zambia. PLoS ONE. 2015;10(4):e0122169.

    Article  Google Scholar 

  26. DeGregorio G, Manga S, Kiyang E, et al. Implementing a fee-for‐service cervical cancer screening and treatment program in Cameroon: challenges and opportunities. Oncologist. 2017;22(7):850.

    Article  Google Scholar 

  27. Ramogola-Masire D, de Klerk R, Monare B, Ratshaa B, Friedman HM, Zetola NM. Cervical cancer prevention in HIV-infected women using the see and treat approach in Botswana. J Acquir Immune Defic Syndr. 2012;59(3).

  28. Asgary R, Staderini N, Mthethwa-Hleta S, et al. Evaluating smartphone strategies for reliability, reproducibility, and quality of VIA for cervical cancer screening in the Shiselweni region of Eswatini: a cohort study. PLoS Med. 2020;17(11):e1003378.

    Article  Google Scholar 

  29. Yeates K, Erwin E, Mtema Z, et al. Smartphone-enhanced training, QA, monitoring, and evaluation of a platform for secondary prevention of cervical cancer: Opportunities and challenges to implementation in Tanzania. JCO Glob Oncol. 2020;6:1114–23.

    Article  Google Scholar 

  30. Mittra I, Mishra GA, Singh S, et al. A cluster randomized, controlled trial of breast and cervix cancer screening in Mumbai, India: methodology and interim results after three rounds of screening. Int J Cancer. 2010;126(4):976–84.

    Article  Google Scholar 

  31. World Health Organization. Monitoring national cervical cancer prevention and control programmes: quality control and quality assurance for visual inspection with acetic acid (VIA)-based programmes. Geneva: WHO; 2013.

    Google Scholar 

  32. Sankaranarayanan R, Esmy PO, Rajkumar R, et al. Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial. The Lancet. 2007;370(9585):398–406.

    Article  Google Scholar 

  33. Arbyn M, Sankaranarayanan R, Muwonge R, et al. Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India. Int J Cancer. 2008;123(1):153–60.

    Article  Google Scholar 

  34. Selmouni F, Belakhel L, Sauvaget C, et al. Evaluation of the national cervical cancer screening program in Morocco: achievements and challenges. J Med Screen. 2019;26(3):162–8.

    Article  Google Scholar 

  35. Bigoni J, Gundar M, Tebeu PM, et al. Cervical cancer screening in sub-saharan Africa: a randomized trial of VIA versus cytology for triage of HPV‐positive women. Int J Cancer. 2015;137(1):127–34.

    Article  Google Scholar 

  36. Hoffmann TC, Glasziou PP, Boutron I et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ. 2014;348.

  37. Adsul P, Manjunath N, Srinivas V, Arun A, Madhivanan P. Implementing community-based cervical cancer screening programs using visual inspection with acetic acid in India: a systematic review. Cancer Epidemiol. 2017;49:161–74.

    Article  Google Scholar 

  38. International Agency for Research on Cancer. CanScreen5–Cervical Cancer Screen-and-treat Quantitative Data Collection Form. 2021. Available from: https://canscreen5.iarc.fr/CervixQSTEN.pdf. Accessed 14 08 2023.

Download references

Acknowledgements

Not applicable.

Funding

This publication is supported by a grant awarded by the Norwegian Research Council (project number 288638) to the Center for Global Health Inequalities Research (CHAIN) at the Norwegian University for Science and Technology (NTNU).

Author information

Authors and Affiliations

Authors

Contributions

TB, LC, AT, CB, IM, AC, and PB contributed substantially to the conception and design of the project.TB and LC were responsible for the literature search, study selection, and extraction of data.All authors contributed to the interpretation and analysis of data.All authors contributed to drafting the article and revising it critically for important intellectual content.All authors have provided the final approval of the version to be published.

Corresponding author

Correspondence to Thea Beate Brevik.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Disclaimer

Where authors are identified as personnel of the International Agency for Research on Cancer/World Health Organization, the authors alone are responsible for the views expressed in this article and they do not necessarily represent the decisions, policy, or views of the International Agency for Research on Cancer /World Health Organization.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Brevik, T.B., da Matta Calegari, L.R., Mosquera Metcalfe, I. et al. Training health care providers to administer VIA as a screening test for cervical cancer: a systematic review of essential training components. BMC Med Educ 23, 712 (2023). https://doi.org/10.1186/s12909-023-04711-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12909-023-04711-5

Keywords